Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysisMaria Guarino, Andrea Casadei‐Gardini, Luca Viganò et al.|Digestive and Liver Disease|2018Cited by 61
Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19Erica Villa, Antonia D’Errico, Federico Casari et al.|Blood Advances|2021Cited by 59
Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: a prospective clinical studyRosina Maria Critelli, Erica Villa|Cell Death and Disease|2017Cited by 55
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction modelFrancesco Vizzutti, Filippo Schepis, Ciro Celsa et al.|Hepatology|2022Cited by 55
Intrinsic Tumor Aggressiveness Dictates Hypoxia-Driven Metabolic Programs in Hepatocellular CarcinomaFabiola Milosa, Erica Villa|International Journal of Molecular Sciences|2026Cited by 0